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The letter by Dols-Icardo et al. reports an independent analysis of [18F]fluorodeoxyglucose 
positron emission tomography and whole-genome sequencing data from the Alzheimer's 
Disease Neuroimaging Initiative cohort that nicely complements our recent report1 
addressing brain structural features associated with a REST missense variant as well as the 
recent findings reported by Lu et al.2 We found the minor allele of rs3796529 in the REST 
gene protective for rate of hippocampal volume loss in individuals with APOE ε3/ε3 
genotype. Further analyses3 in response to a letter from Dr. Yankner4 indicated that 
rs3796529 was significantly associated with hippocampal CA1 subfield volume in both mild 
cognitive impairment (MCI) and Alzheimer's disease (AD) patients, with minor allele 
carriers having larger CA1 volumes. However, rs3796529 was not associated with 
hippocampal CA1 volume in older adults who were in the cognitively normal control group.
By contrast, Dols-Icardo et al. found that both controls and MCI patients carrying at least 
one minor allele of the REST singlenucleotide polymorphism had increased glucose 
metabolism in the medial temporal region compared to noncarriers, suggesting the 
neuroprotective role of the REST missense variant extends to controls. The role of REST as a 
protective factor in controls notably supports the previous findings by Lu et al.2 However, 
the influence of rs3796529 on brain glucose metabolism was found for only the left or right 
medial temporal region, and the statistical images were not corrected for the multiple 
comparisons at the voxel or cluster level. Thus, these intriguing findings warrant further 
investigation and ideally an independent replication.
In summary, Dols-Icardo et al.'s findings reaffirm earlier observations that the REST 
rs3796529 variant may be a protective factor for MCI. Additional longitudinal analyses 
would help to clarify the protective role of REST through the AD continuum as well as its 
relevance for prediction of within-subject change. Additional experimental studies are 
needed to determine the potential of REST as a target for therapeutic and preventative 
interventions.
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